Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Fukuda, Akihiro
Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome. [electronic resource] - Nephrology (Carlton, Vic.) Apr 2010 - 321-6 p. digital
Publication Type: Journal Article
1440-1797
10.1111/j.1440-1797.2009.01256.x doi
Angiotensin II Type 1 Receptor Blockers--pharmacology
Animals
Blood Pressure--drug effects
Disease Models, Animal
Eplerenone
Fluorescent Antibody Technique
Intracellular Signaling Peptides and Proteins--metabolism
Losartan--pharmacology
Male
Membrane Proteins--metabolism
Mineralocorticoid Receptor Antagonists--pharmacology
Nephrosis, Lipoid--chemically induced
Podocytes--drug effects
Proteinuria--chemically induced
Puromycin Aminonucleoside
Rats
Rats, Sprague-Dawley
Sialoglycoproteins--metabolism
Spironolactone--analogs & derivatives
Time Factors
Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome. [electronic resource] - Nephrology (Carlton, Vic.) Apr 2010 - 321-6 p. digital
Publication Type: Journal Article
1440-1797
10.1111/j.1440-1797.2009.01256.x doi
Angiotensin II Type 1 Receptor Blockers--pharmacology
Animals
Blood Pressure--drug effects
Disease Models, Animal
Eplerenone
Fluorescent Antibody Technique
Intracellular Signaling Peptides and Proteins--metabolism
Losartan--pharmacology
Male
Membrane Proteins--metabolism
Mineralocorticoid Receptor Antagonists--pharmacology
Nephrosis, Lipoid--chemically induced
Podocytes--drug effects
Proteinuria--chemically induced
Puromycin Aminonucleoside
Rats
Rats, Sprague-Dawley
Sialoglycoproteins--metabolism
Spironolactone--analogs & derivatives
Time Factors